Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Cancer Medicine|October 6, 2017
Social determinants of stage IV anal cancer and the impact of pelvic radiotherapy in the metastatic settingMichael C Repka, Nima Aghdam, Andrew W Karlin, et al.
Radiation Oncology (London, England)|November 10, 2012
Physician self-reported treatment of brain metastases according to patients' clinical and demographic factors and physician practice settingMarie-Adele S Kress, Naren Ramakrishna, Solomon B Makgoeng, et al.
JCO Oncology Practice|April 9, 2020
Variations in Retroperitoneal Soft Tissue Sarcoma Outcomes by Hospital Type: A National Cancer Database AnalysisAnthony M Villano, Alexander Zeymo, Kitty S Chan, et al.
Frontiers in Oncology|January 14, 2014
Yttrium-90 Radioembolization in Patients with Hepatocellular Carcinoma Who have Previously Received SorafenibNitesh Rana, Andrew Wenhua Ju, Michael Bazylewicz, et al.
Surgery|July 26, 2020
Radical excision for retroperitoneal soft tissue sarcoma: A national propensity-matched outcomes analysisAnthony M Villano, Alexander Zeymo, Aradhya Nigam, et al.
International Journal of Radiation Oncology, Biology, Physics|July 27, 2010
Preoperative chemoradiation for rectal cancer using capecitabine and celecoxib correlated with posttreatment assessment of thymidylate synthase and thymidine phosphorylase expressionKeith R Unger, Davis A Romney, Mehmet Koc, et al.
Surgery|February 6, 2022
National evaluation of patterns and predictors of underuse of multimodal therapy for high-risk extremity soft tissue sarcomaAradhya Nigam, Nathan Aminpour, Alexander Zeymo, et al.
Cancers|February 27, 2026
Vascular Resection, Reconstruction, and Divestment in Pancreatoduodenectomy: Expanding Boundaries in Pancreatic Cancer SurgeryDimitrios Moris, Brian M Nguyen, Alexander Kroemer, et al.
Cancer Medicine|June 9, 2020
Ethnicity and insurance status predict metastatic disease presentation in prostate, breast, and non-small cell lung cancerNima Aghdam, Mary McGunigal, Haijun Wang, et al.
Frontiers in Oncology|June 28, 2024
Comparative analysis of plan quality and delivery efficiency: ZAP-X vs. CyberKnife for brain metastases treatmentYing Niu, Abdul Rashid, Jui-Min Lee, et al.
Pageof 2